Unknown

Dataset Information

0

High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.


ABSTRACT: Fluoroquinolone resistance in Mycobacterium tuberculosis can be conferred by mutations in gyrA or gyrB. The prevalence of resistance mutations outside the quinolone resistance-determining region (QRDR) of gyrA or gyrB is unclear, since such regions are rarely sequenced. M. tuberculosis isolates from 1,111 patients with newly diagnosed culture-confirmed tuberculosis diagnosed in Tennessee from 2002 to 2009 were screened for phenotypic ofloxacin resistance (>2 ?g/ml). For each resistant isolate, two ofloxacin-susceptible isolates were selected: one with antecedent fluoroquinolone exposure and one without. The complete gyrA and gyrB genes were sequenced and compared with M. tuberculosis H37Rv. Of 25 ofloxacin-resistant isolates, 11 (44%) did not have previously reported resistance mutations. Of these, 10 had novel polymorphisms: 3 in the QRDR of gyrA, 1 in the QRDR of gyrB, and 6 outside the QRDR of gyrA or gyrB; 1 did not have any gyrase polymorphisms. Polymorphisms in gyrA codons 1 to 73 were more common in fluoroquinolone-susceptible than in fluoroquinolone-resistant strains (20% versus 0%; P = 0.016). In summary, almost half of fluoroquinolone-resistant M. tuberculosis isolates did not have previously described resistance mutations, which has implications for genotypic diagnostic tests.

SUBMITTER: Devasia R 

PROVIDER: S-EPMC3318526 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.

Devasia Rose R   Blackman Amondrea A   Eden Svetlana S   Li Haijing H   Maruri Fernanda F   Shintani Ayumi A   Alexander Charles C   Kaiga Anne A   Stratton Charles W CW   Warkentin Jon J   Tang Yi-Wei YW   Sterling Timothy R TR  

Journal of clinical microbiology 20111221 4


Fluoroquinolone resistance in Mycobacterium tuberculosis can be conferred by mutations in gyrA or gyrB. The prevalence of resistance mutations outside the quinolone resistance-determining region (QRDR) of gyrA or gyrB is unclear, since such regions are rarely sequenced. M. tuberculosis isolates from 1,111 patients with newly diagnosed culture-confirmed tuberculosis diagnosed in Tennessee from 2002 to 2009 were screened for phenotypic ofloxacin resistance (>2 μg/ml). For each resistant isolate, t  ...[more]

Similar Datasets

| S-EPMC4068501 | biostudies-literature
| S-EPMC4808166 | biostudies-literature
| S-EPMC4284962 | biostudies-literature
| S-EPMC4763791 | biostudies-literature
| S-EPMC3095995 | biostudies-literature
| S-EPMC163415 | biostudies-other
| S-EPMC3318379 | biostudies-literature
| S-EPMC4376704 | biostudies-literature
| S-EPMC4767988 | biostudies-literature
| S-EPMC3299416 | biostudies-literature